Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Kidney disease > Kidney transplant > Induction therapy/primary immunosuppression

Published:

12 March 2015

Authors:

Saturnino LTM, Ceccato MGB, Cherchiglia ML, Andrade EG, Giordano LC, Acurcio FA

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Saturnino LTM, Ceccato MGB, Cherchiglia ML, Andrade EG, Giordano LC, Acurcio FA. Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD009637. DOI: 10.1002/14651858.CD009637.pub2